Kerry Group plc ("Kerry" or the "Company") announces that on 03 July 2024 it purchased the following number of its A ordinary shares of €0.125 each (the "Ordinary Shares") on the London Stock Exchange from Goldman Sachs International. The Ordinary Shares purchased will be cancelled.
London Stock Exchange
Number of Ordinary Shares purchased:
56,590
Highest price paid per Ordinary Share:
€ 76.4000
Lowest price paid per Ordinary Share:
€ 75.5500
Volume weighted average price paid per Ordinary Share:
€ 76.0063
The Ordinary Shares purchased form part of Kerry's intention to buyback Ordinary Shares of a total value of up to €300 million in the period up to 19 December 2024 ("Buyback Programme"). This Buyback Programme was announced on 3 May 2024 and formally commenced on 7 May 2024.
Following settlement of the above transactions and subsequent share cancellation Kerry will have 172,173,952 Ordinary Shares in issue (excluding treasury shares).
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the "Market Abuse Regulation") (including as it forms part of retained EU law in the United Kingdom ('UK') from time to time and, where relevant, pursuant to the UK's European Union (Withdrawal) Act 2018 and the UK's Market Abuse (Amendment) (EU Exit) Regulations 2019), a detailed breakdown of individual trades made by Goldman Sachs International as riskless principal on behalf of Kerry on Euronext Dublin as part of the Buyback Programme for subsequent repurchase by the Company on the London Stock Exchange is scheduled to this announcement.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.
